In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
|Slideshows|November 11, 2019
Top 5 gynecologic studies from October 2019
Author(s)Judith M. Orvos, ELS, Ben Schwartz
Ranging from sexual function among cancer patients to how lifetime estrogen exposure affects late-life cognition to state strategies to address opioid use, these were Contemporary OB/GYN's selections for the top gynecologic studies published in October 2019.
Advertisement
Advertisement
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
Well-woman visit upgrade, post-miscarriage ultrasound findings, cardio-obstetrics framework
3
Real-world data link fezolinetant to fewer nighttime awakenings
4
Evident ovarian cancer screening test: What SOARA will measure
5